By Erica L. Mayer, MD, MPH There has been remarkable recent progress in identifying effective treatments for patients with metastatic breast cancer – that is, cancer that has spread beyond the breast and underarm lymph nodes to other parts of the body.
By Lola Baltzell I have been a metastatic breast cancer patient at Dana-Farber for over four years now. “Metastatic” means the cancer has spread beyond the breast. I have an amazing team of providers, especially my oncologist Ann Partridge and nurse practitioner Anne Kelly.
Helping a loved one face cancer is never easy, but the challenge is especially daunting when the patient is your own child. Our clinicians at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center work with pediatric cancer patients and their families every day. Lisa Diller, MD, Anna Muriel, MD, and Jorge […]
by Erica Mayer, MD, MPH In 1974, when First Lady Betty Ford announced that she had undergone a mastectomy for breast cancer, it was a turning point in people’s willingness to talk about the disease. Prior to that, discussing cancer of any type, even with one’s family or friends, was […]
Cancer scientists use a wide variety of techniques to study the growth and development of tumor cells. Laboratory research often focuses on individual cells or tissue samples, but to learn how cancers grow and respond to therapies in living organisms, scientists rely on other experimental models. In recent years, zebrafish […]
Alyssa Ywuc was a 23-year-old nursing student when she was diagnosed with leukemia. After seeing first-hand the work of oncology nurses as a patient, she decided to specialize in oncology nursing. We talked with Alyssa about both sides of the cancer experience – her time as a patient and her future […]
The gaudy green image you see below is not an avant-garde sculpture, but the most detailed image yet made of the protein “spike” that allows HIV – the virus that causes AIDS – to latch onto and enter human blood cells.
Aromatase inhibitors (AIs), such as Arimidex, Aromasin, and Femara, have proven to be more effective than previous hormonal treatments for treating both early and advanced breast cancer in post-menopausal women whose tumors are dependent on estrogen. Compared with tamoxifen, these drugs are less likely to cause blood clots or raise […]
It was glitter and glue when patients, visitors, and Dana-Farber staff gathered on Oct. 4 to create art on an unusual canvas – bras. Hosted by Friends’ Place and Dana-Farber’s Creative Arts Program, the “Decorate a Brassiere” art therapy event allowed attendees to creatively honor Breast Cancer Awareness Month.
This Sunday, 7,000 runners will step up to the starting line for the 12th annual Boston Athletic Association (BAA) Half Marathon presented by Dana-Farber and the Jimmy Fund. 500 of them will run not only to set a personal record on the 13.1-mile course, but also to raise money for Dana-Farber. […]
By Mark Kieran, MD, PhD In 2006, a group of Egyptian doctors arrived at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to seek our help. Could we teach them how to care for the rising numbers of children with cancer, in their own country?